MedTrace Logo

Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa

NCT03848728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1988

Last updated 2024-10-23

Study results available
· View outcomes & findings →

Summary

The goal of this study is to evaluate the effect of a combination intervention on long-term HIV viral load (VL) suppression among HIV-infected adolescents and young adults 15-24 years of age. The study will take place in 28 rural HIV clinics in western Kenya and southwest Uganda. Clinics will be randomly chosen to either continue to provide study participants standard care or to provide the study intervention, which consists of discussion and counseling on major issues or life events, flexible access to the clinic, and rapid turnaround of VL test results. Participants will take part in the study for at least 2 years.

Conditions

Interventions

OTHER

SEARCH Youth combination intervention

* Administration of life-stage assessment tool * Structured choice clinic access * Rapid feedback of VL results * Provider e-collaboratives with chat groups for discussions of challenging cases using de-identified information

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Infectious Diseases Research Collaboration, Uganda

    collaborator OTHER

  • Kenya Medical Research Institute

    collaborator OTHER

  • Makerere University

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Diane V Havlir, MD · University of California, San Francisco

  • Moses R Kamya, MBChB, MMed, PhD · Makerere University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2023-06-23
Completion
2023-06-23

Countries

  • Kenya
  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03848728 on ClinicalTrials.gov